Cystatin C in risk prediction after transcatheter aortic valve replacement: a retrospective analysis

ConclusionsThe CKDCys classification could better assess the risk than the CKDCr classification in patients undergoing TAVR. CKDCys stage 3b and stage 4  + 5 correlated with adverse outcomes.

Source: ESC Heart Failure - June 6, 2022 Category: Cardiology Authors: Kensuke Kuwabara, Kan Zen, Masaki Yashige, Kazuaki Takamatsu, Nobuyasu Ito, Yoshito Kadoya, Michiyo Yamano, Tetsuhiro Yamano, Takeshi Nakamura, Hitoshi Yaku, Satoaki Matoba Tags: Original Article Source Type: research